Cardiff Oncology, Inc. (CRDF)
1.01
+0.01
(+1.20%)
USD |
NASDAQ |
Aug 25, 09:59
Cardiff Oncology Total Assets (Quarterly) : 37.33M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 37.33M |
| March 31, 2026 | 49.17M |
| December 31, 2025 | 61.88M |
| September 30, 2025 | 63.78M |
| June 30, 2025 | 75.74M |
| March 31, 2025 | 84.81M |
| December 31, 2024 | 97.19M |
| September 30, 2024 | 62.90M |
| June 30, 2024 | 66.05M |
| March 31, 2024 | 74.04M |
| December 31, 2023 | 81.64M |
| September 30, 2023 | 88.45M |
| June 30, 2023 | 97.46M |
| March 31, 2023 | 106.55M |
| December 31, 2022 | 116.19M |
| September 30, 2022 | 123.63M |
| June 30, 2022 | 131.26M |
| March 31, 2022 | 139.20M |
| December 31, 2021 | 149.68M |
| September 30, 2021 | 141.31M |
| June 30, 2021 | 143.73M |
| March 31, 2021 | 129.57M |
| December 31, 2020 | 136.90M |
| September 30, 2020 | 39.45M |
| June 30, 2020 | 30.13M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.82M |
| December 31, 2019 | 14.06M |
| September 30, 2019 | 11.92M |
| June 30, 2019 | 13.87M |
| March 31, 2019 | 14.53M |
| December 31, 2018 | 14.17M |
| September 30, 2018 | 17.92M |
| June 30, 2018 | 21.77M |
| March 31, 2018 | 10.41M |
| December 31, 2017 | 12.28M |
| September 30, 2017 | 12.22M |
| June 30, 2017 | 12.56M |
| March 31, 2017 | 33.93M |
| December 31, 2016 | 43.95M |
| September 30, 2016 | 53.00M |
| June 30, 2016 | 56.72M |
| March 31, 2016 | 66.01M |
| December 31, 2015 | 71.45M |
| September 30, 2015 | 77.02M |
| June 30, 2015 | 43.64M |
| March 31, 2015 | 45.83M |
| December 31, 2014 | 28.90M |
| September 30, 2014 | 32.76M |
| June 30, 2014 | 36.19M |
| March 31, 2014 | 24.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ocugen, Inc. | 124.21M |
| CytomX Therapeutics, Inc. | 381.23M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.80M |
| Shareholders Equity (Quarterly) | 26.53M |
| Debt to Equity Ratio | 0.0172 |
| Current Ratio | 3.296 |
| Net Debt Paydown Yield | 0.20% |